I haven't done my research properly here aside from a casting look several months ago, but I love it when the market throws a tantrum over a stock dipping into a loss because of higher R&D or amortisation as such costs do not necessarily persist and should improve the competitive edge of a company in the long term.
I've got a starting stake today, but will do more research before acquiring more.
Ann: Update on 1H 22 results and FY2022 outlook, page-35
-
- There are more pages in this discussion • 592 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add APX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.5¢ |
Change
0.015(1.90%) |
Mkt cap ! $179.5M | |||
| Open | High | Low | Value | Volume |
| 82.5¢ | 86.0¢ | 79.0¢ | $9.671M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 341894 | 80.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 81.0¢ | 13131 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| APX (ASX) Chart |